Sysmex Corporation (SSMXF)

Market Cap	10.60B
Revenue (ttm)	3.40B
Net Income (ttm)	358.40M
Shares Out	n/a
EPS (ttm)	0.57
PE Ratio	29.59
Forward PE	n/a
Dividend	0.22 (1.46%)
Ex-Dividend Date	Mar 28, 2025

Volume	227
Average Volume	10,947
Open	15.80
Previous Close	15.00
Day's Range	15.00 - 15.80
52-Week Range	14.73 - 20.73
Beta	0.81
RSI	37.45
Earnings Date	Aug 6, 2025

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers;...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1968
• Employees: 10,042
• Stock Exchange: OTCMKTS
• Ticker Symbol: SSMXF

Financial Performance

In 2024, Sysmex's revenue was 508.64 billion, an increase of 10.21% compared to the previous year's 461.51 billion. Earnings were 53.67 billion, an increase of 8.12%.

Financial numbers in JPY